Ayala Pharmaceuticals Inc (ADXS)

[cab033]

I have a question for those who really believe a BO is likely and near.

My question is, why would a BP buy this for $10, $20, or $50 per share, yet Instituional/Fund investors who invest in this sector, not even touch this at sub $2?

This is a legitimate question. And before it is mentioned of the few that did add shares, ownership is somewhere around the 40% right now.

These institutions try to get in ahead of BO so they can reap the rewards of the run up. Here it seems like they have been trying to get out during the steady drop. Why would they not be taking a risk at $1.XX? Seems like a good risk/reward for them considering so many on this board calling for a 1,000% - 5,000% return over the near term. I just find it hard to believe that this board has a better understanding on what is comming for ADXS vs a professional fund with teams of researchers. Especially considereing the track record of this boards predictions over the last 4 years of calling for a BO (anywhere from $200 SP all the way down to $50 SP).